Merck & Co.
213 E Grand Avenue, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA 02141
United States
4216 articles about Merck & Co.
-
Merck & Co., Inc. (JOBS) Ends Research Collaboration Deal with SurModics Inc.
9/18/2008
-
U.S. Merck & Co., Inc.'s (JOBS) Japan Unit to Slash Sales Branches
9/17/2008
-
New Merck & Co., Inc. Osteoporosis Drug Boosts Bone Density
9/17/2008
-
Taconic Farms, Inc. Taps Former Merck & Co., Inc. Executive for VP of Quality Systems & Regulatory Affairs Post
9/16/2008
-
Odanacatib, Merck & Co., Inc.'s Investigational Cathepsin K Inhibitor, Increased Bone Mineral Density (BMD) Over Two Years at Key Fracture Sites in Phase IIB Study
9/16/2008
-
Merck & Co., Inc. Vaccine Wins OK for Vaginal Cancer
9/15/2008
-
Outsourcing the Drug Industry; U.S. Giants Rushing To Partner With Indian And Chinese Companies--Tapping Their Brainpower And Saving Millions Of Dollars In The Search For Breakthrough Treatments
9/10/2008
-
Proscape Technologies Announces the First Annual Closed Loop Marketing Executive Summit, Featuring Education from Leading Life Sciences Companies, Including AstraZeneca PLC, Johnson & Johnson, Merck & Co., Inc. and Wyeth
9/9/2008
-
Merck & Co., Inc. Release: Five New Studies at Major Medical Meeting Further Demonstrate Clinical Experience for JANUVIA(TM) (sitagliptin)
9/9/2008
-
Merck & Co., Inc. Release: Federal Court of Appeals in a Divided Decision Reverses District Court Ruling Dismissing VIOXX(R) Securities Class Action
9/9/2008
-
Iroko Pharmaceuticals and Merck & Co., Inc. Release: New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
9/2/2008
-
U.S. FDA to Review Merck & Co., Inc. (JOBS), Schering-Plough Corporation (JOBS) Data on Vytorin Cancer Risk
8/22/2008
-
Merck & Co., Inc. Cancer Shot Not Economical for Adult Women, Harvard School of Public Health Study Finds
8/21/2008
-
Merck & Co., Inc. Release: The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
8/18/2008
-
Diakron Pharmaceuticals Licenses Anticoagulant Drug Candidate from Merck & Co., Inc. (JOBS); Orchid Pharma Partners with Diakron
8/13/2008
-
Enrollment in Phase IIb Clinical Trial for I-vation(TM) TA (MK-0140) Suspended Pending Review of Study Design by Merck & Co., Inc.
8/11/2008
-
US FDA Warns of Muscle Harm When Ingredients in Heart Drugs Merck & Co., Inc., Abbott Laboratories Combine
8/8/2008
-
FDA Approves Merck & Co., Inc.'s Expanded Label for CANCIDAS(R) (caspofungin acetate) as the First and Only Echinocandin Therapy for the Treatment of Pediatric Patients (3 months and older) with Indicated Fungal Infections
8/6/2008
-
Dynavax Technologies Corporation and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
8/6/2008
-
Ariad Pharmaceuticals, Inc. to Receive $2.5 Million from Partner Merck & Co., Inc.
8/6/2008